Co-administering BPC-157 with daily diazepam prevented the development of tolerance and physical dependence in rats, while also reducing withdrawal seizures — a remarkable protective effect.
Active at nanogram dosesBPC-157 prevented diazepam tolerance and dependence at both microgram and nanogram doses — extremely potent protective effect
What the researchers found
BPC-157 co-administration with chronic diazepam (10 days) prevented tolerance development, maintained anticonvulsant efficacy, and reduced withdrawal seizure severity at both 10 μg/kg and 10 ng/kg doses in rats.
Why it matters
Benzodiazepine dependence is a major clinical problem. A co-treatment that prevents tolerance and dependence without interfering with the therapeutic effect would transform how these medications are used.
How the study worked
Animal study in rats. BPC-157 (10 μg/kg or 10 ng/kg IP) was co-administered with diazepam (5 mg/kg IP) twice daily for 10 days. Anticonvulsant efficacy, tolerance, and pentylenetetrazol-induced withdrawal seizures were assessed.
What this study cannot tell us
Rat study only. The GABAergic interaction mechanism was not fully elucidated. Translation to human benzodiazepine use is unknown. 10-day timeframe may not reflect longer-term dependence patterns.
How to read the evidence
Preliminary animal evidence with clear behavioral endpoints and dose-response data, but no human studies or mechanistic confirmation.
When this study was published
Published in 1999. BPC-157's interaction with GABAergic and dopaminergic systems has been studied further, but human data remains absent.
The bigger picture
Millions of people take benzodiazepines for anxiety and insomnia, but dependence develops within weeks. A peptide that prevents this dependence while maintaining therapeutic benefit could eliminate one of psychiatry's most challenging medication problems.
Questions still open
- Could BPC-157 help patients taper off benzodiazepines?
- Does BPC-157 affect GABA receptors directly or modulate them indirectly?
- Would this protective effect extend to other sedative-hypnotic drugs?
Common questions
What is benzodiazepine dependence?
Could BPC-157 help people on benzodiazepines?
Read the original research
The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam.
The Chinese journal of physiology, 42(3), 171-9
Citation
Jelovac, N; Sikiric, P; Rucman, R; Petek, M; Perovic, D; Marovic, A; Anic, T; Seiwerth, S; Mise, S; Pigac, B; Duplancie, B; Turkovic, B; Dodig, G; Prkacin, I; Stancic-Rokotov, D; Zoricic, I; Aralica, G; Sebecic, B; Ziger, T; Slobodnjak, Z. (1999). The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam.. The Chinese journal of physiology, 42(3), 171-9.